Korea's news agency Yonhap reported that the executive, surnamed Lee, allegedly decided to tamper with evidence of a plot to inflate the value of Samsung's stake in a joint venture with a U.S. company.
The agency approved Truxima for three lymphoma indications, whereas European regulators approved it last year for all the same indications as the reference product, Roche's Rituxan.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.